Clinical trial · Observational
Effectiveness of Trans-Arterial Chemo Embolization for Hepatocellular Carcinoma on Follow-Up CT Triphasic Liver
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
"HCC is a major challenge due to greater recurrence rates and variable treatment responses. TACE is widely used, but its success relies on accurate follow-up imaging. CT Triphasic Liver Imaging plays a vital role in assessing treatment response, guiding clinical decisions, and improving patient outcomes. The purpose of this study is to investigate the relationship between response of treatment, gender, age, and the cause of HCC. The purpose of the study is to evaluate how well TACE (trans-arterial chemoembolization) works for patients with HCC.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Hepatocellular Carcinoma | Hepatocellular Carcinoma | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| CT Imagesa in HCCT | Diagnostic Test | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- CT Images
- interventionNames
- Diagnostic Test: CT Imagesa in HCCT
Primary outcomes (1)
- measure
- self admisistered questioner
- timeFrame
- 12 Months
- description
- self-administered questionnaire for the evaluation of HCCT, having a score range from 0 to 50. The more the score shows that issues worsen.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 65 Years
Show eligibility criteria text
Inclusion Criteria: * Both Male and Female. * Patients diagnosed with HCC who underwent TACE. * Patients with no portal vein tumor thrombus (PVTT) or no extra Extrahepatic Metastases at the time of initial TACE treatment. * Patients who underwent TACE within last your years from the study start date. Exclusion Criteria: * Patients with incomplete or missing medical records and imaging studies. * Patients with a history of severe comorbidities that might interfere with treatment response evaluation * Patients who were contraindicated for CT scans at the time of follow-up. * Patients that are contradicted with CT scan. * Patient who underwent TACE more than four years before the study period.
References
Publications (0)
Data not yet available